Management of MDS with del(5q)

ESH eLearning, M. Jädersten, 165425

Apoptosis and erythroid differentiation

ESH eLearning, G. Courtois, 165650

Autophagy and erythroblast maturation

ESH eLearning, V. Betin, 165651

Epidemiology, pathophysiology and treatment of high altitude polycythemia (Monges’s disease)

ESH eLearning, J.P. Richalet, 165652

Large-scale erythroid differentiation using iPS cells

ESH eLearning, L. Douay, 165653

Not so benign haematology: anaemia of the elderly

ESH eLearning, C.N. Roy, 165654

Novel erythropoiesis-stimulating agents: a new era in anaemia management

ESH eLearning, I. Macdougall, 165655

Malaria: pathology and cytoadherence

ESH eLearning, A. Merckx, 165656

Modifier genes in sickle cell disease

ESH eLearning, J. Elion, 165657

Current diagnostics in- and classification of NHL, including demonstration of diagnostic pitfalls

ESH eLearning, A. Rosenwald, 165472

Staging and response evaluation, including the role of PET/CT scanning, including demonstration of pitfalls in imaging

ESH eLearning, M. Hutchings, 165473

Treatment options, including clinical cases, controversies

ESH eLearning, A. Hagenbeek, 165474

Treatment options, including clinical cases, controversies

ESH eLearning, M. Dreyling, 165475

Current diagnostics and staging of MM, including demonstration of diagnostic pitfalls

ESH eLearning, H. Goldschmidt, 165476

Stratification and response evaluation, including demonstration of pitfalls

ESH eLearning, H. Avet-Loiseau, 165477

Treatment options, including clinical cases, controversies

ESH eLearning, M.V. Mateos, 165478

Treatment options, including clinical cases, controversies

ESH eLearning, G. Merlini, 165479

State of the art including methods for graft facilitation

ESH eLearning, H.E. Broxmeyer, 165531

Cord blood subpopulations and reprogrammed cells

ESH eLearning, G. Koegler, 165532

State of the art

ESH eLearning, E.J. Shpall, 165533

Hematopoietic stem cell expansion to overcome non-engraftment

ESH eLearning, J. Wagner, 165534

The present and future challenges of gene therapy for sickle cell disease

ESH eLearning, F. Mavilio, 165535

Biomarker – based personalized medicine

ESH eLearning, S. Paczesny, 165536

Tregs for immune modulation

ESH eLearning, J. Wagner, 165537

Assesment of HLA diversity in Marseille cord blood bank

ESH eLearning, C. Chabannon, 165538

Human cord blood (CB) derived unrestricted somatic stem cells (USSCS) significantly improves survival and wound healing in an animal model of recessive dystrophic epidermolysis bullosa (RDEB)

ESH eLearning, M. Cairo, 165539

Crosstalk between umbilical cord/cord blood endothelial precursors and mesenchymal stromal cells in promoting new blood vessel formation

ESH eLearning, S. Watt, 165540

Treatment of mesenchymal stromal cells with immunosuppressive drugs increases their immunoregulatory potency

ESH eLearning, J. Girdlestone, 165541

The Italian Cord Blood Platelet Gel project

ESH eLearning, P. Rebulla, 165542

Increasing use of hematopoietic stem cell transplantation for ethnic minorities

ESH eLearning, M. Oudshoorn, 165543

Role of non HLA markers for donor selection

ESH eLearning, R. Tamouza, 165544

State of the art

ESH eLearning, E. Baudoux, 165545

Updating the cord blood unit inventory to meet current needs

ESH eLearning, S. Querol, 165546

Role of registries to analyze outcomes data – Eurocord – Netcord

ESH eLearning, V. Rocha, 165547

Sickle cell disease global perspective

ESH eLearning, E. Gluckman, 165548

Is sickle cell disease an autonomic nervous system disorder: what triggers the transition from steady state to crisis?

ESH eLearning, T. Coates, 165549

Haplo-identical related hematopoietic stem cell transplant for sickle cell disease

ESH eLearning, R. Jones, 165550

Epidemiology and treatment of sickle cell in Senegal including hydroxycarbamide, transfusions and chelation in children

ESH eLearning, I. Diagne, 165551

State of the art

ESH eLearning, J. Wagner, 165552

Results of single and double cord blood in adult malignancies: cost efficiency study

ESH eLearning, A. Ruggeri, 165553

Conditioning for cord blood transplant

ESH eLearning, G. Sanz, 165554

Cord blood transplant in children with non malignant disease

ESH eLearning, E. Gluckman, 165555

Cord blood transplantation for adults: what have we learned

ESH eLearning, D. Weisdorf, 165556

Unrelated donor umbilical cord blood transplantation (UCBT) for hemoglobinopathy using reduced intensity conditioning (RIC)

ESH eLearning, A. Abraham, 165557

Outcome analysis of unrelated cord blood transplantation in Korea

ESH eLearning, Y.H. Lee, 165558

Allogeneic hematopoietic stem cell transplantation (HSCT) for treatment of high risk hemoglobinopathy patients lacking a fully HLA-matched sibling donor using a novel myeloablative, reduced toxicity conditioning regimen

ESH eLearning, S. Kharbanda, 165559

Haplo versus cord blood: pros cord blood

ESH eLearning, J. Wagner, 165560

Algorythm of donor choice

ESH eLearning, K. Ballen, 165561

The RTN Policy: a comprehensive algorythm of the allogeneic hematopoietic stem cell transplant for adults with hematological malignancies

ESH eLearning, W. Arcese, 165562

Networks, research tools and cooperation: the example of network research on sickle cell disease in Central Africa

ESH eLearning, L. Tshilolo, 165563

Problems related to the availability of opioids in Africa

ESH eLearning, E. Kafando, 165564

Association for the struggle against sickle cell disease in Niger

ESH eLearning, F. Hima, 165565

Struggle against sickle cell disease Madagascar-France

ESH eLearning, P. Jeannot, 165566

Support association for SCD in Mauritania

ESH eLearning, M. Wane, 165567

Senegalese Association for the struggle against Sickle Cell Disease

ESH eLearning, M. Ndiaye, 165568

Waldenstrom macroglobulinemia

ESH eLearning, Enrica Morra, 38714

Smouldering Myeloma

ESH eLearning, María-Victoria Mateos, 38710

MGUS

ESH eLearning, Shaji Kumar, 38705

Role of Allo

ESH eLearning, Henk Lokhorst, 38707

Role of consolidation / maintenance

ESH eLearning, M Mohty, 38697

Stratification for risk or age

ESH eLearning, Michele Cavo, 38699

Treatment of relapse

ESH eLearning, Michel Delforge, 38701

Treatment of fit elderly patients

ESH eLearning, Antonio Palumbo, 38718

Treatment of younger patients

ESH eLearning, Pieter Sonneveld, 38720

Histone deacetylase

ESH eLearning, Enrique Ocio, 38716

Monoclonal antibodies

ESH eLearning, Sagar LONIAL, 38708

Pomalidomide

ESH eLearning, Thierry Facon, 38702

Carfilzomib

ESH eLearning, Keith Stewart, 38721

MLN9708

ESH eLearning, Roman Hajek, 38703

Renal insufficiency

ESH eLearning, Stefan Knop, 38704

Frailty

ESH eLearning, Alessandra Larocca, 38706

Bone disease

ESH eLearning, Evangelos TERPOS, 38722

Clinical conditions - Side effects

ESH eLearning, Heinz Ludwig, 38709

Imaging

ESH eLearning, Evangelos TERPOS, 38723

New tools for response assessment and prognostic value of CR

ESH eLearning, Bruno Paiva, 38717

Prognostic of cytogenetic abnormalities

ESH eLearning, Hervé Avet-Loiseau, 38698

CRAB and staging

ESH eLearning, Philippe Moreau, 38712

Whole genome sequence

ESH eLearning, Nikhil Munshi, 38715

SNIP and CGH arrays

ESH eLearning, Faith Davies, 38700

Gene expression profiling and miRNA

ESH eLearning, Alberto Rocci, 38719

Welcome address

ESH eLearning, Paul Browne, 39325

Wrap-up of new molecular findings in MDS - time for a new classification?

ESH eLearning, Mario Cazzola, 21313

SCT - decision-making for very high-risk and elderly patients

ESH eLearning, lionel Adès, 21312

Hypomethylating agents in best clinical practice

ESH eLearning, lionel Adès, 21310

How to treat thrombocytopenia and autoimmune features?

ESH eLearning, A Ganser, 21308

Combination drug therapy

ESH eLearning, Guillermo Garcia-Manero, 21307

New experimental drugs

ESH eLearning, Guillermo Garcia-Manero, 21306

New molecular and biological targets for treatment

ESH eLearning, Alan List, 21305

Risk evaluation and treatment

ESH eLearning, Pierre Fenaux, 21304

Juvenile myelomonocytic leunited kingdomemia

ESH eLearning, Charolotte Niemeyer, 21303

Adult CMML: clinical features and treatment

ESH eLearning, DT Bowen, 21302

Spliceosome mutations in different subtypes of MDS

ESH eLearning, Seishi Ogawa, 21300

Clinical features and prognosis

ESH eLearning, Eva Hellstrom-Lindberg, 21299

SF3B1 mutations in MDS with ring sideroblasts

ESH eLearning, Mario Cazzola, 21298

Discussion

ESH eLearning, Ghulam Mufti, 21319

Biology of anaemia and disease progression

ESH eLearning, Jacqueline Boultwood, 21295

Therapeutic recommendations in low- and high-risk MDS

ESH eLearning, Theo De Witte, 21293

Allogeneic stem cell transplantation

ESH eLearning, Nicolaus Kröger, 21291

Hypomethylating agents and chemotherapy

ESH eLearning, Pierre Fenaux, 21290

Immunosuppressive therapy and immunoregulatory drugs (IMiDS)

ESH eLearning, A Ganser, 21289